feed,title,long_url,short_url
Benzinga,President and CEO of Crane Makes $12.23M Sale,https://benzinga.com/news/22/11/29661197/president-and-ceo-of-crane-makes-12-23m-sale,https://bit.ly/3tlGi5O
Benzinga,Tecnoglass Director Sold $636K In Company Stock,https://benzinga.com/news/22/11/29661196/tecnoglass-director-sold-636k-in-company-stock,https://bit.ly/3ElaTqs
Benzinga,Mettler-Toledo Intl Director Trades Company's Stock,https://benzinga.com/news/22/11/29661195/mettler-toledo-intl-director-trades-companys-stock,https://bit.ly/3thhUm7
Benzinga,Head Human Resources of Mettler-Toledo Intl Sold $1.69M In Stock,https://benzinga.com/news/22/11/29661194/head-human-resources-of-mettler-toledo-intl-sold-1-69m-in-stock,https://bit.ly/3tgZW35
Benzinga,Lantern Pharma 10% Owner Trades $1.54M In Company Stock,https://benzinga.com/news/22/11/29661192/lantern-pharma-10-owner-trades-1-54m-in-company-stock,https://bit.ly/3tgZVMz
Benzinga,"Rivian Heads In The Right Direction: Anaysts Lower Price Targets, Remain Cautiously Optimistic",https://benzinga.com/analyst-ratings/analyst-color/22/11/29662572/rivian-heads-in-the-right-direction-anaysts-lower-price-targets-remain-cautiously-o,https://bit.ly/3tgURro
Benzinga,Why Meta Materials Stock Is Falling Sharply,https://benzinga.com/news/earnings/22/11/29662937/why-meta-materials-stock-is-falling-sharply,https://bit.ly/3A0efN6
Benzinga,Lantern Pharma 10% Owner Trades Company's Stock,https://benzinga.com/news/22/11/29661190/lantern-pharma-10-owner-trades-companys-stock,https://bit.ly/3tgZUZ1
Benzinga,30.71M Reasons To Be Bullish On Fulgent Genetics Stock,https://benzinga.com/news/22/11/29661188/30-71m-reasons-to-be-bullish-on-fulgent-genetics-stock,https://bit.ly/3tgZVw3
